Dijon
France
7
2023-04-27
7
2026-05-19
These are the the leading inventors for applications assigned to Oncodesign S.A.:
Oncodesign S.A. based in Dijon, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MACROCYCLIC RIP2-KINASE INHIBITORS
#2 | 2019-05-02 ✅ Patent 10,676,486 granted on 2020-06-09Macrocyclic RIP2 kinase inhibitors
#3 | 2019-02-21 ✅ Patent 10,716,869 granted on 2020-07-21Radiolabeled macrocyclic EGFR inhibitor
#4 | 2017-08-24 ✅ Patent 10,377,772 granted on 2019-08-13Macrocyclic LRRK2 kinase inhibitors
#5 | 2016-01-28 ✅ Patent 9,586,975 granted on 2017-03-07Macrocyclic salt-inducible kinase inhibitors
#6 | 2015-10-08 ✅ Patent 9,370,519 granted on 2016-06-21Macrocyclic FLT3 kinase inhibitors
#7 | 2014-07-24 ✅ Patent 9,096,609 granted on 2015-08-04Macrocyclic LRRK2 kinase inhibitors
Also check out ONCODESIGN S.A.'s (Dijon, France) applicant profile with 7 patent applications submitted.
496518 ⎘